2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputation in Thailand.
Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026, who qualifies, and what options exist in Thailand now.
Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.
Diabetes affects millions across Thailand. Can stem cell therapy help reverse it? Our Bangkok clinic shares real patient outcomes, THB pricing, and what the latest research says about stem cells for diabetes in 2026.
Type 1 diabetes has long been considered a lifelong condition, requiring constant management and insulin therapy. However, recent developments in stem cell research are challenging this notion and offering hope for a potential cure. This article explores the groundbreaking study by Vertex Pharmaceuticals that’s making waves in the diabetes community...
In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, based on longstanding research from Harvard Stem Cell Institute’s Melton Lab, represents one of the first practical applications of embryonic stem...
Les scientifiques développent une approche prometteuse pour traiter le diabète de type 1 en utilisant des cellules souches pour créer des cellules productrices d'insuline (appelées cellules bêta) qui pourraient remplacer les cellules pancréatiques non fonctionnelles. (suite…)
Les personnes atteintes de diabète de type 2 ont tendance à avoir une fonction musculaire plus faible que les autres. Aujourd'hui, une équipe de recherche a découvert que dans le diabète de type 2, un gène spécifique est d'une grande importance pour la capacité des cellules souches musculaires à créer de nouvelles cellules musculaires matures. (suite…)
French 
English 
Chinese 
Russian